Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Prepaid Assets (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Prepaid Assets for 9 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 7780.95% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, up 7780.95%, and an annual FY2025 reading of $1.7 million, up 7780.95% over the prior year.
  • Prepaid Assets was $1.7 million for Q4 2025 at Puma Biotechnology, up from $409000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $11.6 million in Q1 2021 and bottomed at $21000.0 in Q4 2024.
  • Average Prepaid Assets over 5 years is $2.5 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Prepaid Assets plummeted 97.7% in 2024, then soared 7780.95% in 2025.
  • Year by year, Prepaid Assets stood at $2.1 million in 2021, then plummeted by 32.32% to $1.4 million in 2022, then crashed by 36.89% to $912000.0 in 2023, then tumbled by 97.7% to $21000.0 in 2024, then skyrocketed by 7780.95% to $1.7 million in 2025.
  • Business Quant data shows Prepaid Assets for PBYI at $1.7 million in Q4 2025, $409000.0 in Q3 2025, and $722000.0 in Q2 2025.